EA201400628A1 - Трансдермальная терапевтическая система для введения фентанила или его аналога - Google Patents

Трансдермальная терапевтическая система для введения фентанила или его аналога

Info

Publication number
EA201400628A1
EA201400628A1 EA201400628A EA201400628A EA201400628A1 EA 201400628 A1 EA201400628 A1 EA 201400628A1 EA 201400628 A EA201400628 A EA 201400628A EA 201400628 A EA201400628 A EA 201400628A EA 201400628 A1 EA201400628 A1 EA 201400628A1
Authority
EA
Eurasian Patent Office
Prior art keywords
analogue
therapeutic system
transdermal therapeutic
fentanile
introduction
Prior art date
Application number
EA201400628A
Other languages
English (en)
Other versions
EA032150B1 (ru
Inventor
Бьёрн Шурад
Сонья Шмит
Original Assignee
Ацино Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ацино Аг filed Critical Ацино Аг
Publication of EA201400628A1 publication Critical patent/EA201400628A1/ru
Publication of EA032150B1 publication Critical patent/EA032150B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B37/00—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding
    • B32B37/14—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding characterised by the properties of the layers
    • B32B37/26—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding characterised by the properties of the layers with at least one layer which influences the bonding during the lamination process, e.g. release layers or pressure equalising layers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B38/00—Ancillary operations in connection with laminating processes
    • B32B38/0004—Cutting, tearing or severing, e.g. bursting; Cutter details
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B37/00—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding
    • B32B37/14—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding characterised by the properties of the layers
    • B32B37/26—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding characterised by the properties of the layers with at least one layer which influences the bonding during the lamination process, e.g. release layers or pressure equalising layers
    • B32B2037/268—Release layers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2323/00—Polyalkenes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2556/00—Patches, e.g. medical patches, repair patches
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T156/00—Adhesive bonding and miscellaneous chemical manufacture
    • Y10T156/10—Methods of surface bonding and/or assembly therefor
    • Y10T156/1052—Methods of surface bonding and/or assembly therefor with cutting, punching, tearing or severing

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

В изобретении предлагается трансдермальная терапевтическая система для введения фентанила или его аналога через кожу, имеющая самоклеящийся матричный слой, который содержит смесь двух полиизобутиленов с определенным модулем хранения
EA201400628A 2011-11-30 2012-11-22 Трансдермальная терапевтическая система для введения фентанила и способ ее изготовления EA032150B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11191254.9A EP2599478A1 (de) 2011-11-30 2011-11-30 Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff davon
PCT/EP2012/073314 WO2013079386A1 (de) 2011-11-30 2012-11-22 Transdermales therapeutisches system zur verabreichung von fentanyl oder einem analogstoff davon

Publications (2)

Publication Number Publication Date
EA201400628A1 true EA201400628A1 (ru) 2014-09-30
EA032150B1 EA032150B1 (ru) 2019-04-30

Family

ID=47226157

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201400628A EA032150B1 (ru) 2011-11-30 2012-11-22 Трансдермальная терапевтическая система для введения фентанила и способ ее изготовления

Country Status (11)

Country Link
US (1) US20140330223A1 (ru)
EP (2) EP2599478A1 (ru)
JP (1) JP2015502940A (ru)
KR (1) KR101968366B1 (ru)
AR (1) AR089040A1 (ru)
CA (1) CA2850906C (ru)
EA (1) EA032150B1 (ru)
MX (1) MX2014005437A (ru)
UA (1) UA114101C2 (ru)
WO (1) WO2013079386A1 (ru)
ZA (1) ZA201403497B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102014000200A1 (de) * 2014-01-03 2015-07-09 Michael Horstmann Transdermales Therapeutisches System
JP6940407B2 (ja) * 2014-12-19 2021-09-29 キンデーバ ドラッグ デリバリー リミティド パートナーシップ フェンタニルを含む経皮薬物送達デバイス
JP6832456B2 (ja) 2017-03-24 2021-02-24 イー インク カリフォルニア， エルエルシー 活性分子の投与率を調整するための荷電または磁気粒子を含むマイクロセル送達システム
TW201840307A (zh) 2017-03-24 2018-11-16 美商伊英克加利福尼亞有限責任公司 用於遞送活性分子的微胞系統
DE102017115701B4 (de) * 2017-07-12 2022-03-03 Lts Lohmann Therapie-Systeme Ag Fampridin-TTS
US11266832B2 (en) 2017-11-14 2022-03-08 E Ink California, Llc Electrophoretic active delivery system including porous conductive electrode layer
KR102797900B1 (ko) 2019-11-27 2025-04-21 이 잉크 코포레이션 전기 침식 밀봉층을 갖는 마이크로셀들을 포함하는 유익제 전달 시스템
EP4236926A4 (en) 2020-10-29 2024-08-28 E Ink Corporation MICROCELL SYSTEMS FOR DELIVERY OF BENEFICIAL AGENTS
EP4236927A4 (en) 2020-10-29 2024-10-16 E Ink Corporation MICROCELL SYSTEMS FOR DELIVERY OF HYDROPHILIC ACTIVE MOLECULES

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588580B2 (en) * 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
AU601528B2 (en) 1986-12-22 1990-09-13 Ortho-Mcneil Pharmaceutical, Inc. Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
DE19830898A1 (de) 1998-07-10 2000-01-13 Hexal Ag Vorrichtung zur Verbesserung der Entnahmefähigkeit von in Beuteln verpackten, haftklebend ausgerüsteten, flächigen Substratabschnitten
JP3943724B2 (ja) * 1998-07-31 2007-07-11 東光薬品工業株式会社 フェンタニル含有経皮投与マトリックス型貼付剤
ES2270746T3 (es) 2001-03-16 2007-12-01 Alza Corporation Parche transdermico para administrar fentanilo.
JP4199485B2 (ja) * 2002-06-07 2008-12-17 久光製薬株式会社 貼付剤
AU2003272878A1 (en) 2002-09-13 2004-04-30 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch
TWI296531B (en) * 2002-10-18 2008-05-11 Hisamitsu Pharmaceutical Co Transdermal adhesive preparations for topical administration of fentanyl
KR100563194B1 (ko) * 2003-11-14 2006-03-21 (주) 에프디엘 펜타닐을 유효성분으로 함유하는 경피투여제제
JP4745747B2 (ja) 2004-08-12 2011-08-10 日東電工株式会社 フェンタニル含有貼付製剤
US8252319B2 (en) * 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
SI1814531T1 (sl) * 2004-10-21 2010-10-29 Durect Corp Transdermalni dostavni sistem
JP4786196B2 (ja) * 2005-02-24 2011-10-05 ライオン株式会社 ゲル組成物及びその製造方法
AU2007255724B2 (en) * 2006-06-09 2012-05-10 Dainippon Sumitomo Pharma Co., Ltd. Novel tape preparation
US8647664B2 (en) * 2006-07-14 2014-02-11 Hisamitsu Pharmaceutical Co., Inc. Adhesive preparation
EP2111857A1 (de) 2008-04-25 2009-10-28 Acino AG Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff hiervon
IN2012DN00845A (ru) 2009-07-21 2015-06-26 Mylan Inc
EP2295046B1 (de) 2009-09-14 2012-12-19 Acino AG Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff davon

Also Published As

Publication number Publication date
US20140330223A1 (en) 2014-11-06
WO2013079386A1 (de) 2013-06-06
EA032150B1 (ru) 2019-04-30
CA2850906A1 (en) 2013-06-06
AR089040A1 (es) 2014-07-23
JP2015502940A (ja) 2015-01-29
UA114101C2 (xx) 2017-04-25
KR101968366B1 (ko) 2019-04-11
MX2014005437A (es) 2014-09-01
KR20140098765A (ko) 2014-08-08
EP2785334C0 (de) 2024-09-25
ZA201403497B (en) 2015-12-23
EP2785334A1 (de) 2014-10-08
CA2850906C (en) 2022-05-10
EP2785334B1 (de) 2024-09-25
EP2599478A1 (de) 2013-06-05

Similar Documents

Publication Publication Date Title
EA201400628A1 (ru) Трансдермальная терапевтическая система для введения фентанила или его аналога
ECSP24031979A (es) Compuestos terapéuticamente activos y sus métodos de uso
CR20140321A (es) Sistema de administracion transdermica que contiene buprenofina
CR20150647A (es) Sistema de liberación transdérmica
GT201300215A (es) Inhibidores de glucosilceramida sintasa
MX2016003486A (es) Inhibidores de glucosilceramida sintasa para el tratamiento de enfermedades.
NI201600071A (es) Compuestos de inhibidor de autotaxina
DK2651410T3 (da) Transdermalt terapeutisk system til administration af et aktivstof
UY35210A (es) Inhibidores de autotaxina
MX2016000696A (es) Compuestos terapeuticos activos y sus usos.
BR112012028136A2 (pt) terapia de combinaçao
CL2014001704A1 (es) Derivados de amida ciclica como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa; composicion farmaceutica que los comprende y el uso de los mismos en la prevencion o tratamiento de enfermedades tales como la diabetes.
EA201390616A1 (ru) ЛЕЧЕНИЕ НАРУШЕНИЙ, АССОЦИИРОВАННЫХ С ГЕНОМ MeCP2
BR112016006848A2 (pt) métodos e composições para distribuição transdérmica de uma quantidade não sedativa de dexmedetomidina
CL2014002978A1 (es) Combinaciones farmacéuticas que contienen un inhibidor de 11-beta-hidroxiesteroide dehidrogenasa para el tratamiento de trastornos metabólicos
CO6920289A2 (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib.
BR112014013878A8 (pt) emplastro
DK2621561T3 (da) Fleksibelt fastgørelsesmiddel til lægemiddeladministrationsanordning
BR112014017834A8 (pt) Sistema de distribuição de fármacos
MX2015000485A (es) Tratamiento de esclerosis multiple con una combinacion de laquinimod y fampridina.
BR112014012945A2 (pt) sistemas, dispositivos e métodos para acionar um modulador interferométrico analógico
EA201490390A1 (ru) Вспомогательное средство для накладывания
EA201490041A1 (ru) Пластырь, содержащий диклофенак и тиоколхикозид
BR112015024703A2 (pt) formulação farmacêutica, método de tratamento e/ou prevenção de restenose e kit para o tratamento e/ou prevenção de restenose
CL2014001643A1 (es) Compuestos derivados de quinolina, como inhibidores de la enzima pde10a; composicion farmaceutica que los comprende; y su uso para el tratamiento de un trastorno psiquiatrico o neurodegenerativo.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM KG TM